BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun HL, Sun BL, Chen DW, Chen Y, Li WW, Xu MY, Shen YY, Xu ZQ, Wang YJ, Bu XL. Plasma α-synuclein levels are increased in patients with obstructive sleep apnea syndrome. Ann Clin Transl Neurol 2019;6:788-94. [PMID: 31020003 DOI: 10.1002/acn3.756] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Guo M, Ji X, Liu J. Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease. Front Aging Neurosci 2022;14:919343. [DOI: 10.3389/fnagi.2022.919343] [Reference Citation Analysis]
2 Kaczyńska K, Orłowska ME, Andrzejewski K. Respiratory Abnormalities in Parkinson's Disease: What Do We Know from Studies in Humans and Animal Models? Int J Mol Sci 2022;23:3499. [PMID: 35408858 DOI: 10.3390/ijms23073499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Falla M, Giardini G, Angelini C. Recommendations for traveling to altitude with neurological disorders. J Cent Nerv Syst Dis 2021;13:11795735211053448. [PMID: 34955663 DOI: 10.1177/11795735211053448] [Reference Citation Analysis]
4 Burtscher J, Syed MMK, Keller MA, Lashuel HA, Millet GP. Fatal attraction - The role of hypoxia when alpha-synuclein gets intimate with mitochondria. Neurobiol Aging 2021;107:128-41. [PMID: 34428721 DOI: 10.1016/j.neurobiolaging.2021.07.017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Lestón Pinilla L, Ugun-Klusek A, Rutella S, De Girolamo LA. Hypoxia Signaling in Parkinson's Disease: There Is Use in Asking "What HIF?". Biology (Basel) 2021;10:723. [PMID: 34439955 DOI: 10.3390/biology10080723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Weihs A, Frenzel S, Grabe HJ. The Link Between Obstructive Sleep Apnoea and Neurodegeneration and Cognition. Curr Sleep Medicine Rep 2021;7:87-96. [DOI: 10.1007/s40675-021-00210-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Burtscher J, Mallet RT, Burtscher M, Millet GP. Hypoxia and brain aging: Neurodegeneration or neuroprotection? Ageing Res Rev 2021;68:101343. [PMID: 33862277 DOI: 10.1016/j.arr.2021.101343] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
8 Burtscher J, Syed MMK, Lashuel HA, Millet GP. Hypoxia Conditioning as a Promising Therapeutic Target in Parkinson's Disease? Mov Disord 2021;36:857-61. [DOI: 10.1002/mds.28544] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
9 Bogale TA, Faustini G, Longhena F, Mitola S, Pizzi M, Bellucci A. Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives. Front Immunol 2021;12:611761. [PMID: 33679750 DOI: 10.3389/fimmu.2021.611761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]